Last reviewed · How we verify

NCT07250529: LBBP-AHRE

Left Bundle Branch Pacing vs Right Ventricular Pacing on AHRE Burden in Patients With Preserved LVEF

Recruiting now NA Last updated 13 March 2026
What this trial tests

NA trial testing Right Ventricular Pacing in Atrial Fibrillation (AF) in 244 participants. Currently enrolling.

Timeline
5 February 2026
Primary endpoint
20 April 2029
20 June 2029

Quick facts

Lead sponsorUniversity Hospital of Patras
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment244
Start date5 February 2026
Primary completion20 April 2029
Estimated completion20 June 2029
Sites1 location across Greece

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital of Patras

Who can join

18 and older, any sex, with Atrial Fibrillation (AF) or Pacemaker Therapy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This prospective, randomized controlled trial aims to evaluate the effect of left bundle branch pacing (LBBP) compared with conventional right ventricular (RV) pacing on the cumulative duration (total time) of atrial high-rate episodes (AHREs) in patients with preserved left ventricular ejection fraction (LVEF) who are expected to require frequent ventricular pacing. Atrial High-Rate Episodes (AHREs) are defined as episodes of atrial tachyarrhythmia that are automatically recorded by device diagnostics and detected by implanted cardiac devices. These episodes usually have an atrial rate ≥170 beats per minute and a duration ≥6 minutes. AHREs are linked to a higher risk of thromboembolic events and clinical atrial fibrillation (AF), and they may indicate subclinical AF or other atrial tachyarrhythmias. Chronic RV pacing has been linked to mechanical and electrical dyssynchrony, which may encourage atrial remodeling and the development of AF. LBBP provides a more physiological ventricular activation and may reduce atrial tachyarrhythmia time (AHRE time). Patients with LVEF \>50% and atrioventricular (AV) conduction disorders requiring a dual-chamber pacemaker will be randomized to either conventional RV septal pacing or LBBP.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Right Ventricular Pacing

Trials testing the same drug.

Other recruiting trials for Atrial Fibrillation (AF)

Currently open trials in the same condition.

Other University Hospital of Patras trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07250529.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing